ACRV
#3949
Acrivon Therapeutics, Inc. - Common Stock
1.9 0 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.52%
Variación mensual
-4.04%
Variación en los últimos 6 meses
+24.18%
Cambio anual
+3.26%
Cierres anteriores
1.9 1
Open
1.9 1
Mínimo
1.8 7
Máximo
1.9 3
Financials
- Market Capitalization 81.42 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.19
Relación precio/flujo de caja
464.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3941 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 0.44 USD | -8.33% | -16.98% | -57.28% | -76.72% | 82.67 M USD | ||
| 3948 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.86 USD | -2.27% | -8.51% | -13.13% | -53.26% | 81.78 M USD | ||
| 3952 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.04 USD | -3.70% | -9.57% | -15.45% | -53.57% | 80.91 M USD | ||
| 3958 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.42 USD | +2.44% | +13.51% | +31.25% | -67.44% | 79.74 M USD |